Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Assistance Publique – Hôpitaux de Paris · Sorbonne Université · +11 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,089
total citations
- FWCI
- 36.02
- Percentile
- 100%
- References
- 38
Citations per year
Authors
15- LBLaurent BeaugerieCorresponding
Assistance Publique – Hôpitaux de Paris, Sorbonne Université, Hôpital Saint-Antoine
- NBNicole Brousse
Université Paris Cité, Hôpital Necker-Enfants Malades, Assistance Publique – Hôpitaux de Paris
- ABAnne‐Marie Bouvier
Université de Bourgogne
- JFJean Frédéric Colombel
Lille’s Cardiology Hospital, Centre Hospitalier Universitaire de Lille
- MLMarc Lémann
Université Paris Cité, Délégation Paris 7, Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris
Topics & keywords
Topics
Keywords
- Medicine
- Thiopurine methyltransferase
- Inflammatory bowel disease
- Internal medicine
- Lymphoproliferative disorders
- Gastroenterology
- Hazard ratio
- Ulcerative colitis
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.